AbCellera Insider Buying Surge: CEO and CFO Stack 10K Shares as Stock Climbs 92% This Month
Insider buying surges at AbCellera (ABCL) as CEO, CFO, and Montalbano pile on shares, signaling confidence amid a 92% monthly rally.
3 minutes to read
ABCELLERA BIOLOGICS INC
CFO Andrew Booth Fuels Optimism with $10.32 Share Surge at AbCellera – Insider Buying Signals Strong Confidence in Biotech Future
AbCellera CFO Andrew Booth buys 37,200 shares at $10.32, boosting insider confidence after a new public offering that pushed stock to a 52‑week high.
3 minutes to read
AbCellera Insider Charitable Sale: 50,000 Shares Donated, Holdings Stay Strong—No Impact on Growth Outlook
AbCellera insider sale: Hayden R transfers 50k shares for charity—minimal market impact, but signals continued confidence in AbCellera’s antibody‑discovery growth.
3 minutes to read
AbCellera Insider: Director Hayden Michael R Buys 111,701 Zero‑Priced Options, Signaling Strong Long‑Term Optimism Amid 69% YTD Stock Surge
AbCellera insider activity: senior execs buy 111 k zero‑cost options, signaling confidence in its antibody platform—what it means for investors.
3 minutes to read
CFO Andrew Booth’s Massive 250,000‑Share Buy Bolsters Investor Optimism at AbCellera
AbCellera CFO’s $0.19 buy of 250k shares signals internal confidence; investors eye short‑term momentum and future clinical milestones.
3 minutes to read
CFO Andrew Booth Buys 42,600 Shares of AbCellera, Bolstering Insider Confidence Ahead of Q4 Earnings Surge
AbCellera CFO Andrew Booth’s recent share purchase signals rising insider confidence amid strong earnings, a 20% yearly gain, and growing antibody‑pipeline prospects.
2 minutes to read